Resistant hypertension: an unmet treatment need

The Lancet

Volumn 374, Issue 9699, 2009, Pages 1396-1398

  Williams, Bryan ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN A; DARUSENTAN; ERYTHROPOIETIN; HERBACEOUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PLACEBO; SPIRONOLACTONE; STEROID; THIAZIDE DIURETIC AGENT;

ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DIABETES MELLITUS; DOSE RESPONSE; DRUG ABUSE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FLUID RETENTION; GLYCYRRHIZA; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LOW DRUG DOSE; OBESITY; PERIPHERAL EDEMA; PRIORITY JOURNAL; RESISTANT HYPERTENSION; SENESCENCE; SIDE EFFECT;

EID: 70350128801     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61600-7     Document Type: Note

References (7)

1. Calhoun D.A., Jones D., Trextor S., et al. Resistant hypertension: diagnosis, evaluation, and treatment. a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51 (2008) 1403-1419
2. Williams B., Lindholm L.H., and Sever P. Systolic blood pressure is all that matters. Lancet 371 (2008) 2219-2221
3. Higgens B., Williams B., and for the Guideline Development Group. Pharmacological management of hypertension. Clin Med 7 (2007) 612-616
4. Weber M.A., Black H., Bakris G., et al. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet (2009) 10.1016/S0140-6736(09)61500-2 published online Sept 14.
5. Lane D.A., Shah S., and Beevers D.G. Low-dose spironolactone in the management of resistant hypertension: a surveillance study. J Hypertens 25 (2007) 891-894
6. Chapman N., Dobson J., Wilson S., et al., on behalf of the Anglo-Scandinavian Cardiac Outcomes Trial Investigators. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 49 (2007) 839-845
7. Krum H., Schlaich M., Whitbourn R., et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373 (2009) 1275-1281